Then there's the investors. Folks who invest in a biotech's stock, stay on top of its clinical progress, keep an eye on the risks and potential, talk openly and objectively about them. There are a couple of investors here.
Who will prove to have had it right from the start? The “No can tell, too small – stay out early” crowd? Or, the “Can’t be anything but good –- get in early” crowd
After the fact analysis is always 20/20. The question is how does one deal with the possibilities when there is insufficient information.
It's called risk management.
Some investors have invested only what they can afford to lose so that if 2-73 does not preform as expected in P2/3 their lifestyle will not be negatively affected.
Other investors see the potential rewards of 2-73 being so good that they are willing to risk more investment money and a failure will have some negative effects on their lifestyle or investing future.
Some investors here have said they have invested 100% in AVXL because they see the rewards as huge and the risk as very low at this point.
It's all about the risk-reward continuum and how much pain you are willing to accept if things go pear shaped.
Of course, if you are convinced that there is no possibility of failure then mortgaging the house is a reasonable choice.